Salama, M.M.; Zaghloul, R.A.; Khalil, R.M.; El-Shishtawy, M.M.
Sitagliptin Potentiates the Anti-Neoplastic Activity of Doxorubicin in Experimentally-Induced Mammary Adenocarcinoma in Mice: Implication of Oxidative Stress, Inflammation, Angiogenesis, and Apoptosis. Sci. Pharm. 2022, 90, 42.
https://doi.org/10.3390/scipharm90030042
AMA Style
Salama MM, Zaghloul RA, Khalil RM, El-Shishtawy MM.
Sitagliptin Potentiates the Anti-Neoplastic Activity of Doxorubicin in Experimentally-Induced Mammary Adenocarcinoma in Mice: Implication of Oxidative Stress, Inflammation, Angiogenesis, and Apoptosis. Scientia Pharmaceutica. 2022; 90(3):42.
https://doi.org/10.3390/scipharm90030042
Chicago/Turabian Style
Salama, Mohamed M., Randa A. Zaghloul, Rania M. Khalil, and Mamdouh M. El-Shishtawy.
2022. "Sitagliptin Potentiates the Anti-Neoplastic Activity of Doxorubicin in Experimentally-Induced Mammary Adenocarcinoma in Mice: Implication of Oxidative Stress, Inflammation, Angiogenesis, and Apoptosis" Scientia Pharmaceutica 90, no. 3: 42.
https://doi.org/10.3390/scipharm90030042
APA Style
Salama, M. M., Zaghloul, R. A., Khalil, R. M., & El-Shishtawy, M. M.
(2022). Sitagliptin Potentiates the Anti-Neoplastic Activity of Doxorubicin in Experimentally-Induced Mammary Adenocarcinoma in Mice: Implication of Oxidative Stress, Inflammation, Angiogenesis, and Apoptosis. Scientia Pharmaceutica, 90(3), 42.
https://doi.org/10.3390/scipharm90030042